London
· Delayed Price · Currency is GBP · Price in CHF Kuros Biosciences AG Statistics
Total Valuation
LON:0RHR has a market cap or net worth of GBP 759.03 million. The enterprise value is 744.23 million.
| Market Cap | 759.03M |
| Enterprise Value | 744.23M |
Important Dates
The next estimated earnings date is Wednesday, August 13, 2025.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +3.76% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 25.71M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 11.40 |
| PB Ratio | 14.66 |
| P/TBV Ratio | 35.40 |
| P/FCF Ratio | 421.07 |
| P/OCF Ratio | 274.23 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -196.81 |
| EV / Sales | 10.80 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 412.86 |
Financial Position
The company has a current ratio of 2.14, with a Debt / Equity ratio of 0.03.
| Current Ratio | 2.14 |
| Quick Ratio | 1.63 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.66 |
| Debt / FCF | 0.88 |
| Interest Coverage | 0.72 |
Financial Efficiency
Return on equity (ROE) is -6.44% and return on invested capital (ROIC) is 0.11%.
| Return on Equity (ROE) | -6.44% |
| Return on Assets (ROA) | 0.09% |
| Return on Invested Capital (ROIC) | 0.11% |
| Return on Capital Employed (ROCE) | 0.17% |
| Revenue Per Employee | 545,897 |
| Profits Per Employee | -30,996 |
| Employee Count | 122 |
| Asset Turnover | 0.97 |
| Inventory Turnover | 1.18 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +173.15% in the last 52 weeks. The beta is 0.92, so LON:0RHR's price volatility has been similar to the market average.
| Beta (5Y) | 0.92 |
| 52-Week Price Change | +173.15% |
| 50-Day Moving Average | 20.35 |
| 200-Day Moving Average | 19.73 |
| Relative Strength Index (RSI) | 57.74 |
| Average Volume (20 Days) | 4,907 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, LON:0RHR had revenue of GBP 66.60 million and -3.78 million in losses. Loss per share was -0.10.
| Revenue | 66.60M |
| Gross Profit | 59.18M |
| Operating Income | 94,317 |
| Pretax Income | -2.95M |
| Net Income | -3.78M |
| EBITDA | 1.81M |
| EBIT | 94,317 |
| Loss Per Share | -0.10 |
Balance Sheet
The company has 15.88 million in cash and 1.58 million in debt, giving a net cash position of 14.30 million.
| Cash & Cash Equivalents | 15.88M |
| Total Debt | 1.58M |
| Net Cash | 14.30M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 51.78M |
| Book Value Per Share | 1.37 |
| Working Capital | 21.03M |
Cash Flow
In the last 12 months, operating cash flow was 2.77 million and capital expenditures -965,209, giving a free cash flow of 1.80 million.
| Operating Cash Flow | 2.77M |
| Capital Expenditures | -965,209 |
| Free Cash Flow | 1.80M |
| FCF Per Share | n/a |
Margins
Gross margin is 88.85%, with operating and profit margins of 0.14% and -5.68%.
| Gross Margin | 88.85% |
| Operating Margin | 0.14% |
| Pretax Margin | -4.43% |
| Profit Margin | -5.68% |
| EBITDA Margin | 2.72% |
| EBIT Margin | 0.14% |
| FCF Margin | 2.71% |
Dividends & Yields
LON:0RHR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.76% |
| Shareholder Yield | -3.76% |
| Earnings Yield | -0.50% |
| FCF Yield | 0.24% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LON:0RHR has an Altman Z-Score of 11.67.
| Altman Z-Score | 11.67 |
| Piotroski F-Score | n/a |